All News #Library
Others
3SBio 2025 Results: Revenue Tops RMB-10B on R&D & Deals
31 Mar 2026 //
PR NEWSWIRE
Pfizer in deal with China`s 3SBio to license cancer drug candidate
20 May 2025 //
REUTERS
3SBio announces 2021 interim results, with strong growth in core businesses
26 Aug 2021 //
PRNEWSWIRE
Sorrento and 3SBio Announce CAR-T Joint Venture in China
07 Jun 2016 //
PR NEWSWIRE

Market Place
Sourcing Support